NCT00085748View on ClinicalTrials.gov

Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

May 31, 2005

Conditions
Schizophrenia
Interventions
DRUG

paliperidone ER

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00085748 - Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia | Biotech Hunter | Biotech Hunter